Zydus Lifescience Walk-in-Interview

Join Telegram

Zydus Lifesciences Limited is holding walk-in interviews for Quality Control / QC-Micro on August 20, 2022. Find the below details to apply and attend walk an interview at AHMEDABAD

Leading Indian pharmaceutical business Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is a fully integrated, international healthcare provider. It has excellent capabilities across the whole pharmaceutical value chain and extensive domain understanding in the field of healthcare. Zydus has developed a reputation among Indian pharmaceutical businesses for offering comprehensive and full healthcare solutions, from formulations to active pharmaceutical components and animal healthcare goods to wellness items. The extensive history and pedigree of Zydus are one of its most notable characteristics. The company was established way back in the 1950s. Mr. Ramanbhai B. Patel (late), a first-generation industrialist and a legend in the field of Indian pharmaceuticals, founded the company in 1952.

Zydus Lifescience Walk-in-Interview


Job Role Description: 

  • Department Name: Quality Control  / QC-Micro
  • Designation For: Officer / Executive / Sr. Executive
  • Experience Required: 2-6 yrs
  • Qualification Required: B.Sc / M.Sc / B.Pharma
  • Work Location: Ahmedabad

Walk-in Details

Walk-In Date and time: 20th August 2022
Time: 10.00 AM – 04.00 PM

Location Details: Plot No.Sarkhej-Bavla Road, Sarkhej, Ahmedabad – 382213, India. Zydus Lifesciences Ltd.

Walk More: Cipla Limited – Walk-In Drive

Leave a Comment

Your email address will not be published.

Join Telegram

Get Direct Jobs Notification

This will close in 15 seconds

Granules India Pvt. Limited-Walk-In Interviews 10 Largest Pharmaceutical Companies in USA List of the Best Paying Jobs in the Healthcare Industry USA. Lupin Biotech Limited -Walk-In Drive on 21, Aug 2022 Zydus receives Form 483 from the USFDA for 4 observations. क्या पैन किलर आपकी kidney को मार रही है? SUN PHARMA – Walk-In Interviews for Pharma candidates Purdue Pharma, Sacklers reach $6 billion deal USA